Agenda and minutes

Venue: Mulberry Place, 5 Clove Crescent, London E14 2BG

Contact: Philippa Sewell
tel. no.: 020 7332 1426  Email:

No. Item


Welcome and Introductions


The Chair welcomed everyone to the meeting and advised of a change in the order of agenda items: item 8 London Cancer Project Update would now be taken as item 6.

 ...  view the full minutes text for item 1.


Apologies for absence and notice of any substitutions


Apologies for absence were received from Councillor David Edgar and Common Councilman Wendy Mead. Apologies were also received from Dr Penny Bevan (Director of Public Health Hackney) and Sue Milner (Director of Public Health Newham).

 ...  view the full minutes text for item 2.


Declarations of Interest


Councillor Ben Hayhurst declared a non-pecuniary interest in the London Cancer Project Update by virtue of knowing Nick Kennell (NHS England), and Councillor Winston Vaughan declared a non-pecuniary interest in the same item by virtue of being a member of the Association for Prostate Awareness.

 ...  view the full minutes text for item 3.


Minutes of the previous meeting pdf icon PDF 77 KB


The Committee gave consideration to the minutes of the meeting held on 20 November 2013.


RESOLVED –That the minutes of the meeting of the Committee held on 20 November 2013 be agreed as a correct record.

 ...  view the full minutes text for item 4.


Actions and matters arising from the previous meeting


There were no matters arising.

 ...  view the full minutes text for item 5.


Moorfields Eye Hospital pdf icon PDF 647 KB

Additional documents:


The Chair welcomed Project Manager Elizabeth Smith and Chief Executive John Pelly from the Moorfields Eye Hospital NHS Foundation Trust.


Mr Pelly advised Members that the document circulated with the agenda set out the reasons for the move and why the Kings Cross area had been chosen, as well as the engagement document used in a consultation exercise that concluded on 14th February.


Ms Smith reported that this initial consultation had lasted 12 weeks and had liaised with patients and Clinical Commissioning Groups (CCGs) via a questionnaire, drop-in sessions, open days and online communication and social media. She added that of the 59 responses received 87% were positive about the move.


Councillor Luke Akehurst opened the questioning, asking whether Moorfields were considering changing their name?


Mr Pelly responded that a new name was being considered to reflect the integrated clinical and research institute with UCL, but that “Moorfields” would still feature.


Councillor Terrance Paul asked for more details concerning borrowings and funding for the new site.


Mr Pelly replied that exact figures were unavailable as they would depend on the final choice of site (i.e. whether it was lease or freehold) but they were currently estimating that the project would cost in the region of £300million; £75million to be raised through charitable sources, £50-100million from UCL, £30million from Moorfields, and £60million borrowed from government sources.


Councillor Ben Hayhurst queried where the majority of patients came from?


Mr Pelly confirmed that referral figures for Newham, City & Hackney and Tower Hamlets had been circulated with the papers, and that the majority of patients were from neighbouring boroughs.


The Moorfields site on City Road saw 30% of the ophthalmology work in Central London as generally complex issues couldn’t be treated at satellite sites. He reported that some presence would

 ...  view the full minutes text for item 6.


Care Quality Commission Report into Barts Health NHS Trust pdf icon PDF 469 KB

Additional documents:


The Chairman welcomed Seaton Giles from the Care Quality Commission (CQC), and Mark Graver, Kay Riley, Clare Dollery and Pauline Farrell from Barts Health NHS Trust.


Mr Giles gave a short presentation on the inspection of Barts Health NHS Trust. He advised Members that since the appointment of Professor Sir Mike Richards as Chief Inspector of Hospitals new methodology for inspections had been adopted. All hospitals in the UK had been assessed against a number of key indicators which revealed Barts Health to be high risk. It was noted that as this was the first large inspection with the new methodology, no final rating had been given. These would be applied from inspections starting in April 2015.


The inspection asked five questions around eight key areas and an extensive consultation fed into the inspection plan. A large team undertook announced and unannounced visits, and was compiled from a broad range of people to ensure depth and breadth of information. Listening events were held for each named site and Quality Summits were held to discuss how to move forward. Mr Giles briefly summarised three sites where areas for improvements had been found: Newham Hospital, Royal London and Whipps Cross. As well as areas for action, Mr Giles also highlighted the examples of good or outstanding practice for each.


Overall, Members noted that Barts Health provided very good services but there were issues that needed to be addressed. Mr Giles reported that it was early days for a combined Trust and the CQC recognised the scale of the challenges associated with reconciling different cultures and the additional financial pressure. He reported that there was a clear strategy and cohesive leadership, but also a lack of connection between the Executive Board and frontline staff.


Mr Giles advised Members that the Trust were now

 ...  view the full minutes text for item 7.


London Cancer Project Update


The Chairman welcomed Nick Kennell from NHS England to the meeting, who gave a short presentation on the project to create integrated Cancer and Cardiovascular systems to provide local and specialist care.


Members were advised of the level of engagement to date and noted that a report on phase one engagement and an options appraisal report would be available later this month. The London Clinical Senate was undertaking an independent clinical assurance of the proposals, the outcome of which would inform commissioners’ preferred recommendations. These would in turn be outlined in the initial business case to be published by early April.


With regards to the Major Trauma Centre, Mr Kennell outlined the key issues which had been identified from the clinically-led workshop held on 16thJanuary, and reported that a programme of work was being arranged to address these and mitigate risks.


Phase two of the project, a series of engagement events and information, would follow the publication of the initial business case in April, after which planning for implementation and development of commissioner assurance, oversight frameworks and a decision-making business case could begin.


Councillor Ben Hayhurst opened the questioning by asking whether NHS England could guarantee Cancer and Cardiovascular funding would not be reduced as a result of the consolidation of specialist centres?


Mr Kennell responded that NHS England were unable to guarantee funding levels wouldn’t be affected as the cost of delivering services would change, but assured Members that the project was driven by clinical advantages not financial reasons.


Councillor Terrance Paul queried when local residents would start to see the positive impact of consolidating services.


Mr Kennell replied that the figure of 1800 lives being saved as a result of the changes was the potential figure; the next stage was to prepare a schedule of how

 ...  view the full minutes text for item 8.





There was no other business.


As this was the last meeting of the INEL JHOSC in its current format, the Chairman thanked Members for their contribution.

 ...  view the full minutes text for item 9.